Recent Finacing
Recent Raise
Envisia Therapeutics is a clinical-stage ophthalmology biotech developing PRINT particle-based extended-release ocular therapeutics, including ENV515 travoprost for sustained intraocular pressure reduction and intravitreal steroid formulations.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors